Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase by Double-Stranded RNA and Encephalomyocarditis Virus: Involvement of RNase L, Protein Kinase R, and Alternative Pathways
暂无分享,去创建一个
Robert H. Silverman | R. Silverman | M. Iordanov | B. Magun | E. Meurs | J. Paranjape | Aimin Zhou | John Wong | B. Williams | Aimin Zhou | Mihail S. Iordanov | Jayashree M. Paranjape | Bryan R. G. Williams | Eliane F. Meurs | Bruce E. Magun | J. Wong
[1] R. Davis,et al. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Gaestel,et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. , 1999, Nature cell biology.
[3] I. London,et al. Regulation of protein synthesis: activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[4] I. Kerr,et al. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells. , 1981, Nucleic acids research.
[5] L Bibbs,et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.
[6] G L Johnson,et al. Organization and regulation of mitogen-activated protein kinase signaling pathways. , 1999, Current opinion in cell biology.
[7] R. Winzen,et al. Stress-activated Protein Kinase/Jun N-terminal Kinase Is Required for Interleukin (IL)-1-induced IL-6 and IL-8 Gene Expression in the Human Epidermal Carcinoma Cell Line KB* , 1998, The Journal of Biological Chemistry.
[8] A. Matsumori,et al. Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis. , 1999, Journal of the American College of Cardiology.
[9] M. Katze,et al. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. , 1998, Pharmacology & therapeutics.
[10] M. Clemens,et al. Translational control: the cancer connection. , 1999, The international journal of biochemistry & cell biology.
[11] S. Kassis,et al. Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. , 1998, The Journal of pharmacology and experimental therapeutics.
[12] G. Barber,et al. PKR, apoptosis and cancer. , 1999, The international journal of biochemistry & cell biology.
[13] M. Iordanov,et al. Loss of Cellular K+ Mimics Ribotoxic Stress , 1998, The Journal of Biological Chemistry.
[14] M. Iordanov,et al. Ultraviolet Radiation Triggers the Ribotoxic Stress Response in Mammalian Cells* , 1998, The Journal of Biological Chemistry.
[15] Hong Sun,et al. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo , 1993, Cell.
[16] C. Proud,et al. PKR: a new name and new roles. , 1995, Trends in biochemical sciences.
[17] Masahiko Hibi,et al. JNK is involved in signal integration during costimulation of T lymphocytes , 1994, Cell.
[18] R. Davis,et al. Signal transduction by the c-Jun N-terminal kinase. , 1999, Biochemical Society symposium.
[19] M J Clemens,et al. The double-stranded RNA-dependent protein kinase PKR: structure and function. , 1997, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[20] M. Karin,et al. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.
[21] A. Hovanessian,et al. Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. , 1987, The Journal of biological chemistry.
[22] R. Davis,et al. An osmosensing signal transduction pathway in mammalian cells. , 1994, Science.
[23] Jiahuai Han,et al. Characterization of the Structure and Function of a Novel MAP Kinase Kinase (MKK6) (*) , 1996, The Journal of Biological Chemistry.
[24] R. Brimacombe,et al. The structure of ribosomal RNA: a three-dimensional jigsaw puzzle. , 1995, European journal of biochemistry.
[25] Mark R. Player,et al. The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation , 1998, Pharmacology & Therapeutics.
[26] D. Brenner,et al. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. , 1994, The Journal of biological chemistry.
[27] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[28] A. Matsumori,et al. Persistent expression of cytokine in the chronic stage of viral myocarditis in mice. , 1996, Circulation.
[29] Jiahuai Han,et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.
[30] R. Weichselbaum,et al. Activation of p38 Mitogen-activated Protein Kinase by c-Abl-dependent and -independent Mechanisms* , 1996, The Journal of Biological Chemistry.
[31] Wilfred W. Li,et al. The tumor promoter arsenite stimulates AP‐1 activity by inhibiting a JNK phosphatase. , 1996, The EMBO journal.
[32] D. Green,et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.
[33] B. Williams,et al. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. , 1999, Virology.
[34] D. Green,et al. Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death , 1999, Molecular and Cellular Biology.
[35] Y. Ip,et al. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. , 1998, Current opinion in cell biology.
[36] Silverman,et al. rRNA cleavage as an index of ppp(A2'p)nA activity in interferon-treated encephalomyocarditis virus-infected cells , 1983, Journal of virology.
[37] J. Baldassare,et al. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. , 1999, Journal of immunology.
[38] F. Zemlin,et al. Correlation of the expansion segments in mammalian rRNA with the fine structure of the 80 S ribosome; a cryoelectron microscopic reconstruction of the rabbit reticulocyte ribosome at 21 A resolution. , 1998, Journal of molecular biology.
[39] M. Clemens,et al. PKR--a protein kinase regulated by double-stranded RNA. , 1997, The international journal of biochemistry & cell biology.
[40] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[41] Jiahuai Han,et al. Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.
[42] M. Su,et al. Interferon‐γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway , 1998, The EMBO journal.
[43] T. Arakawa,et al. Acceleration of virus‐induced apoptosis by tumor necrosis factor , 1998, FEBS letters.
[44] M. Karin,et al. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. , 1998, Science.
[45] H. Hochkeppel,et al. Significant differences in therapeutic responses to a human interferon-alpha B/D hybrid in Rauscher or Friend murine leukemia virus infections. , 1989, Journal of interferon research.
[46] L. Zon,et al. Protein-Damaging Stresses Activate c-Jun N-Terminal Kinase via Inhibition of Its Dephosphorylation: a Novel Pathway Controlled by HSP72 , 1999, Molecular and Cellular Biology.
[47] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[48] K. Todokoro,et al. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. , 1999, Blood.
[49] W. Fiers,et al. The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. , 1996, The EMBO journal.
[50] R. Davis,et al. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. , 1996, The Journal of biological chemistry.
[51] M. Gorospe,et al. Role of Mitogen-activated Protein Kinase Phosphatase during the Cellular Response to Genotoxic Stress , 1995, The Journal of Biological Chemistry.
[52] M. Gaestel,et al. CREB is activated by UVC through a p38/HOG‐1‐dependent protein kinase , 1997, The EMBO journal.
[53] H. Schaeffer,et al. Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers , 1999, Molecular and Cellular Biology.
[54] R. Silverman. 2-5A-Dependent RNase L: A Regulated Endoribonuclease in the Interferon System , 1997 .
[55] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[56] R. Flavell,et al. Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for tumor necrosis factor-induced cytokine expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[57] I. Kerr,et al. Control of the ppp(a2'p)nA system in HeLa cells. Effects of interferon and virus infection. , 1982, European journal of biochemistry.
[58] K. Miyazawa,et al. Regulation of Interleukin-1β-induced Interleukin-6 Gene Expression in Human Fibroblast-like Synoviocytes by p38 Mitogen-activated Protein Kinase* , 1998, The Journal of Biological Chemistry.
[59] B. Williams,et al. Role of the double-stranded RNA-activated protein kinase (PKR) in cell regulation. , 1997, Biochemical Society transactions.
[60] A. DeFranco,et al. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[61] I. Kerr,et al. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[62] M. Iordanov,et al. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA , 1997, Molecular and cellular biology.
[63] P. Anderson,et al. Trichothecene Mycotoxins Trigger a Ribotoxic Stress Response That Activates c-Jun N-terminal Kinase and p38 Mitogen-activated Protein Kinase and Induces Apoptosis* , 1999, The Journal of Biological Chemistry.
[64] R. Zinkernagel,et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.
[65] B. Poncioni,et al. RauscherまたはFriendマウス白血病ウイルス感染におけるヒトインターフェロン‐αB/Dハイブリッドに対する反応の著明な相違 , 1989 .
[66] Robert H. Silverman,et al. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.
[67] R. Silverman,et al. Impact of RNase L overexpression on viral and cellular growth and death. , 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.